|Complete the Primary DTaP Series With PEDIARIX1,2|
|Vaccine||Birth||2 Months||4 Months||6 months|
|Hepatitis B||Hepatitis B|
- PEDIARIX as a primary series: 3 doses of 0.5 mL each, by intramuscular injection, at 2, 4, and 6 months of age (at intervals of 6 to 8 weeks, preferably 8 weeks)1
- According to the CDC, administration of a total of 4 doses of hepatitis B vaccine is permitted when a combination vaccine containing hepatitis B is administered after the birth dose2
- A 3-dose series of PEDIARIX may be administered to infants born of HBsAg-negative mothers and who received a dose of hepatitis B vaccine at or shortly after birth1
- Data are not available on the safety and effectiveness of using PEDIARIX following one or more doses of a DTaP vaccine from a different manufacturer1
With the GSK DTaP portfolio, patients can start and stay with the same DTaP antigen content as early as 6 weeks of age up until the 7th birthday1,4,5
Maintain the continuity of your schedule with the GSK pediatric vaccine portfolio
|HepB, DTaP, IPV, and Hib From Birth
Through 6 years of Age1,2,4-7,*,†
PEDIARIX gives you more flexibility to “catch up” those appropriate patients who fell behind schedule; Pentacel and Vaxelis are indicated only until the 5th birthday1,8,9
- The recommended dosing interval for PEDIARIX is 6 to 8 weeks, preferably 8 weeks1
- Three doses of PEDIARIX constitute a primary immunization course for diphtheria, tetanus, pertussis, and poliomyelitis and completes the vaccination course for hepatitis B1
- Data are not available on the safety and effectiveness of using PEDIARIX following 1 or more doses of a DTaP vaccine from a different manufacturer
Watch a video about the
schedule flexibility of PEDIARIX
Watch a video about the
GSK portfolio of pediatric vaccines
DTaP=diphtheria, tetanus, and acellular pertussis; IPV=inactivated poliovirus vaccine; HBsAg=hepatitis B surface antigen; CDC=Centers for Disease Control and Prevention; HepB=hepatitis B; Hib=Haemophilus infuenzae type b.
*Data are not available on the safety and effectiveness of using PEDIARIX following one or more doses of a DTaP vaccine different manufacturer.
†GSK’s DTaP-containing vaccines are to be administered according to their approved indications.
References: 1. Prescribing Information for PEDIARIX. 2. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2019. Centers for Disease Control and Prevention website. http://www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html. Reviewed February 5, 2019. Accessed Septmeber 4, 2019. 3. Timing and spacing of immunobiologics. Centers for Disease Control and Prevention website. http://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html. Reviewed January 10, 2019. Accessed September 4, 2019. 4. Prescribing Information for INFANRIX. 5. Prescribing Information for KINRIX. 6. Prescribing Information for HIBERIX. 7. Prescribing Information for ENGERIX-B. 8. Prescribing Information for Pentacel. 9. Prescribing Information for Vaxelis.